Geode Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,125,202
| Closed | -$3.83M | – | 4212 |
|
|
2018
Q3 | $3.83M | Buy |
1,125,202
+81,326
| +8% | +$276K | ﹤0.01% | 2532 |
|
|
2018
Q2 | $3.92M | Buy |
1,043,876
+117,168
| +13% | +$440K | ﹤0.01% | 2468 |
|
|
2018
Q1 | $3.79M | Buy |
926,708
+14,529
| +2% | +$59.4K | ﹤0.01% | 2415 |
|
|
2017
Q4 | $4.24M | Buy |
912,179
+19,003
| +2% | +$88.4K | ﹤0.01% | 2306 |
|
|
2017
Q3 | $6.34M | Buy |
893,176
+41,014
| +5% | +$291K | ﹤0.01% | 2056 |
|
|
2017
Q2 | $6.16M | Buy |
852,162
+43,375
| +5% | +$314K | ﹤0.01% | 2014 |
|
|
2017
Q1 | $4.98M | Buy |
808,787
+58,270
| +8% | +$359K | ﹤0.01% | 2118 |
|
|
2016
Q4 | $4.4M | Buy |
750,517
+27,501
| +4% | +$161K | ﹤0.01% | 2143 |
|
|
2016
Q3 | $3.84M | Buy |
723,016
+3,771
| +0.5% | +$20K | ﹤0.01% | 2130 |
|
|
2016
Q2 | $4.76M | Buy |
719,245
+19,350
| +3% | +$128K | ﹤0.01% | 1948 |
|
|
2016
Q1 | $3.27K | Buy |
699,895
+36,038
| +5% | +$168 | ﹤0.01% | 2144 |
|
|
2015
Q4 | $3.35M | Buy |
663,857
+6,711
| +1% | +$33.9K | ﹤0.01% | 2146 |
|
|
2015
Q3 | $2.31M | Buy |
657,146
+24,878
| +4% | +$87.6K | ﹤0.01% | 2351 |
|
|
2015
Q2 | $6.31M | Buy |
632,268
+5,236
| +0.8% | +$52.3K | ﹤0.01% | 1745 |
|
|
2015
Q1 | $7.98M | Buy |
627,032
+94,762
| +18% | +$1.21M | ﹤0.01% | 1553 |
|
|
2014
Q4 | $7.53M | Buy |
532,270
+9,288
| +2% | +$131K | ﹤0.01% | 1556 |
|
|
2014
Q3 | $7.19M | Buy |
522,982
+4,925
| +1% | +$67.7K | ﹤0.01% | 1513 |
|
|
2014
Q2 | $7.97M | Buy |
518,057
+25,016
| +5% | +$385K | 0.01% | 1472 |
|
|
2014
Q1 | $8.4M | Buy |
493,041
+100,735
| +26% | +$1.72M | 0.01% | 1375 |
|
|
2013
Q4 | $5.08M | Buy |
392,306
+42,350
| +12% | +$548K | ﹤0.01% | 1695 |
|
|
2013
Q3 | $3.54M | Buy |
349,956
+12,108
| +4% | +$122K | ﹤0.01% | 1811 |
|
|
2013
Q2 | $2.52M | Buy |
+337,848
| New | +$2.52M | ﹤0.01% | 1893 |
|